"A lot of pharmacies are cutting my scripts in half. Vyvanse 30 days becomes 15. I started moving my less severe patients to Qelbree. The downside is frequent dosing which is difficult for patients.
About 30% of my non-stimulant patients are on Qelbree now."
They said they needed more AI.
They said it's the next big thing.
They said their AI synthesis in manufacturing works.
They said they will spend more on it.